AI assistant
BIOGEN INC. — Director's Dealing 2023
Jan 17, 2023
30291_dirs_2023-01-17_d83e3ac7-cba5-4e62-856f-52ac20aa1d2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2023-01-05
Reporting Person: Singhal Priya (Head of Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1529.3923 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $0 | 2024-02-18 | Common Stock (1742) | Direct | |
| Restricted Stock Unit | $0 | 2023-03-02 | Common Stock (638) | Direct | |
| Restricted Stock Unit | $0 | 2024-12-08 | Common Stock (852) | Direct | |
| Restricted Stock Unit | $0 | 2025-02-10 | Common Stock (3635) | Direct | |
| Restricted Stock Unit | $0 | 2023-07-01 | Common Stock (315) | Direct | |
| Restricted Stock Unit | $0 | 2025-09-01 | Common Stock (5005) | Direct |
Footnotes
F1: This award was granted to the reporting person on February 18, 2021. The number of Restricted Stock Units ("RSUs") reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
F2: This award was granted to the reporting person on March 2, 2020. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
F3: This award was granted to the reporting person on December 8, 2021 and will vest in three equal installments on each anniversary of the grant date.
F4: This award was granted to the reporting person on February 10, 2022 and will vest in three equal installments on each anniversary of the grant date.
F5: This award was granted to the reporting person on July 1, 2020 and will vest in three equal installments on each anniversary of the grant date.
F6: This award was granted to the reporting person on September 1,
2022 and will vest in three equal installments on each anniversary of the grant date.